Epigenetic management of major psychosis

Clinical Epigenetics

Volumn 2, Issue 2, 2011, Pages 249-256

  Peedicayil, Jacob ^a  

^a NONE

Author keywords

Bipolar disorder; Epigenetic; Psychosis; Schizophrenia

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; AZACITIDINE; BRAIN DERIVED GROWTH FACTOR; BRAIN PROTEIN; CATECHOL METHYLTRANSFERASE; DOXORUBICIN; ENTINOSTAT; FLUOXETINE; IMIPRAMINE; LITHIUM CARBONATE; MICRORNA; NEUROLEPTIC AGENT; PROTEIN MARLIN 1; PSYCHOTROPIC AGENT; REELIN; UNCLASSIFIED DRUG; VALPROIC ACID; ZEBULARINE;

DISEASE ACTIVITY; DNA METHYLATION; DRUG EFFECT; DRUG MECHANISM; DRUG TARGETING; ELECTROCONVULSIVE THERAPY; ENVIRONMENTAL FACTOR; EPIGENETICS; GAD1 GENE; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE LOCATION; GENETIC ASSOCIATION; HISTONE MODIFICATION; HUMAN; LOW DRUG DOSE; MARKER GENE; MOLECULAR PATHOLOGY; NONHUMAN; PREDICTION; PRIORITY JOURNAL; PROMOTER REGION; PSYCHOSIS; PSYCHOTHERAPY; RELN GENE; REVIEW; SCHIZOPHRENIA; THERAPY EFFECT;

EID: 84856268369     PISSN: 18687075     EISSN: 18687083     Source Type: Journal    
DOI: 10.1007/s13148-011-0038-2     Document Type: Review

References (65)

1. Abdolmaleky HM, Cheng K-H, Russo A, Russo A, Smith CL, Faraone SV, Wilcox M, Shafa R, Glatt SJ, Nguyen G, Ponte JF, Thiagalingam S, Tsuang MT (2005) Hypermethylation of the reelin (RELN) promoter in the brain of schizophrenic patients: a preliminary report. Am J Med Genet Neuropsychiatr Genet 134B:60-66 (Pubitemid 40411111)
2. Abdolmaleky HM, Cheng K-H, Faraone SV, Wilcox M, Glatt SJ, Gao F, Smith CL, Shafa R, Aeali B, Carnevale J, Pan H, Papageorgis P, Ponte JF, Sivaraman V, Tsuang MT, Thiagalingam S (2006) Hypomethylation of MB-COMT promoter is major risk factor for schizophrenia and bipolar disorder. Hum Mol Genet 15:3132-3145 (Pubitemid 44607800)
3. Akbarian S, Ruehl MG, Bliven E, Luiz LA, Peranelli AC, Baker SP, Roberts RC, Bunney WE, Conley RC, Jones EG, Tamminga CA, Guo Y (2005) Chromatin alterations associated with downregulated metabolic gene expression in the prefrontal cortex of subjects with schizophrenia. Arch Gen Psychiatry 62:829-840 (Pubitemid 41126876)
4. Best JD, Carey N (2010) Epigenetic therapies for non-oncology indications. Drug Discov Today 15:1008-1014
5. Beveridge NJ, Gardiner E, Carroll AP, Tooney PA, Cairns MJ (2010) Schizophrenia is associated with an increase in cortical micro-RNA biogenesis. Mol Psychiatry 15:1176-1189
6. Borrelli E, Nestler EJ, Allis CD, Sassone-Corsi P (2008) Decoding the epigenetic language of neuronal plasticity. Neuron 60:961-974
7. Cassel S, Carouge D, Gensburger C, Anglard P, Burgun C, Dietrich JB, Aunis D, Zwiller J (2006) Fluoxetine and cocaine induce the epigenetic factors MeCP2 and MBD1 in adult rat brain. Mol Pharmacol 70:487-492 (Pubitemid 44092309)
8. Chen H, Wang N, Burmeister M, McInnis MG (2009) MicroRNA expression changes in lymphoblastoid cell lines in response to lithium treatment. Int J Neuropsychopharmacol 12:975-981
9. Covington HE, Maze I, LaPlant QC, Vialou VF, Ohnishi YN, Berton O, Fass DM, Renthal W, Rush AJ, Wu EY, Ghose S, Krishnan V, Russo SJ, Tamminga C, Haggarty SJ, Nestler EJ (2009) Antidepressant actions of histone deacetylase inhibitors. J Neurosci 29:11451-11460
10. Cyranoski D (2010) Neuropsychiatric diseases: pet project. Nature 466:1036-1038
11. Davies W, Isles AR, Humby T, Wilkinson LS (2007) What are imprinted genes doing in the brain? Epigenetics 2:201-206 (Pubitemid 351308294)
12. De Carvalho DD, You JS, Jones PA (2010) DNA methylation and cellular reprogramming. Trends Cell Biol 20:609-617
13. Dinan TG (2010) MicroRNAs as a target for novel antipsychotics: a systematic review of an emerging field. Int J Neuropsychopharmacol 13:395-404
14. Dong E, Guidotti A, Grayson DR, Costa E (2007) Histone hyperacetylation induces demethylation of reelin and 67-kDa glutamic acid decarboxylase promoters. Proc Natl Acad Sci USA 104:4676-4681 (Pubitemid 47186284)
15. Dong E, Chen Y, Gavin DP, Grayson DR, Guidotti A (2010) Valproate induces DNA demethylation in nuclear extracts from adult mouse brain. Epigenetics 5:730-735
16. Grayson DR (2010) Schizophrenia and the epigenetic hypothesis. Epigenomics 2:341-344
17. Grayson DR, Kundakovic M, Sharma RP (2010) Is there a future for histone deacetylase inhibitors in the pharmacotherapy of psychiatric disorders. Mol Pharmacol 77:126-135
18. Guan J-S, Haggarty SJ, Giacometti E, Dannenberg J-H, Joseph N, Gao J, Nieland TJF, Zhou Y, Wang X, Mazitschek R, Bradner JE, DePinho RA, Jaenisch R, Tsai L-H (2009) HDAC2 negatively regulates memory formation and synaptic plasticity. Nature 459:55-60
19. Guidotti A, Ruzicka W, Grayson DR, Veldic M, Pinna G, Davis JM, Costa E (2007) S-adenosyl methionine and DNA methyltransferase-1 mRNA overexpression in psychosis. Neuroreport 18:57-60 (Pubitemid 46183390)
20. Guidotti A, Dong E, Kundakovic M, Satta R, Grayson DR, Costa E (2009) Characterization of the action of antipsychotic subtypes on valproate-induced chromatin remodeling. Trends Pharmacol Sci 30:55-60
21. Guidotti A, Auta J, Chen Y, Davis JM, Dong E, Gavin DP, Grayson DR, Matrisciano F, Pinna G, Satta R, Sharma RP, Tremolizzo L, Tueting P (2011) Epigenetic GABAergic targets in schizophrenia and bipolar disorder. Neuropharmacology 60:1007-1016
22. Insel TR (2009) Disruptive insights in psychiatry: transforming a clinical discipline. J Clin Invest 119:700-705
23. Huang H-S, Matevossian A, Whittle C, Kim SY, Schumacher A, Baker SP, Akbarian S (2007) Prefrontal dysfunction in schizophrenia involves mixed-lineage leukemia 1-regulated histone methylation at GABAergic gene promoters. J Neurosci 27:11254-11262 (Pubitemid 47621326)
24. Jiang Y, Langley B, Lubin FD, Renthal W, Wood MA, Yasui DH, Kumar A, Nestler EJ, Akbarian S, Beckel-Mitchener AC (2008) Epigenetics in the nervous system. J Neurosci 28:11753-11759
25. Kelly DL, Conley RR, Feldman S, Yu Y, McMahon RP, Richardson CM (2006) Adjunct divalproex or lithium to clozapine in treatment-resistant schizophrenia. Psychiatr Quarterly 77:81-95 (Pubitemid 43060798)
26. Kim AH, Reimers M, Maher B, Williamson V, McMichael O, McClay JL, van den Oord EJ, Riley BP, Kendler KS, Vladimirov VI (2010) MicroRNA expression profiling in the prefrontal cortex of individuals affected with schizophrenia and bipolar disorder. Schizophr Res 124:183-191
27. Kundakovic M, Chen Y, Costa E, Grayson DR (2007) DNA methyltransferase inhibitors coordinately induce expression of the human reelin and glutamic acid decarboxylase 67 genes. Mol Pharmacol 71:644-653 (Pubitemid 46294076)
28. Kundakovic M, Chen Y, Guidotti Y, Grayson DR (2009) The reelin and GAD67 promoters are activated by epigenetic drugs that facilitate the disruption of local repressor complexes. Mol Pharmacol 75:342-354
29. Lewis DA, Sweet RA (2009) Schizophrenia from a neural circuitry perspective: advancing toward rational pharmacological therapies. J Clin Invest 119:706-716
30. Liu L, Li Y, Tollefsbol TO (2008) Gene-environment interactions and epigenetic basis of human diseases. Curr Issues Mol Biol 10:25-36 (Pubitemid 351756576)
31. Ma DK, Jang M-H, Guo JU, Kitabatake Y, Chang M-l, Pow-anpongkul N, Flavell RA, Lu B, Ming G-l, Song H (2009) Neuronal activityinduced Gadd45b promotes epigenetic DNA demethylation and adult neurogenesis. Science 323:1074-1077
32. Ma DK, Marchetto MC, Guo JU, Ming G-l, Gage FH, Song H (2010) Epigenetic choreographers of neurogenesis in the adult mammalian brain. Nat Neurosci 13:1338-1344
33. Masri S, Sassone-Corsi P (2010) Plasticity and specificity of the circadian epigenome. Nat Neurosci 13:1324-1329
34. Martinovich K, Schloesser RJ, Manji HK (2009) Bipolar disorder: from genes to behavior pathways. J Clin Invest 119:726-736
35. Mehler MF (2008) Epigenetic principles and mechanisms underlying nervous system functions in health and disease. Prog Neurobiol 86:305-341
36. Mikkelsen JD, Thomsen MS, Hansen HH, Lichota J (2010) Use of biomarkers in the discovery of novel anti-schizophrenia drugs. Drug Discov Today 15:137-141
37. Mill J, Tang T, Kaminsky Z, Khare T, Yazdanpanah S, Bouchard L, Jia P, Assadzadeh A, Flanagan J, Schumacher A, Wang S-C, Petronis A (2008) Epigenomic profiling reveals DNAmethylation changes associated with major psychosis. Am J Hum Genet 82:696-711 (Pubitemid 351726115)
38. Moreau MP, Bruse SE, David-Rus R, Buyske S, Brzustowicz LM (2011) Altered microRNA expression profiles in postmortem brain samples from individuals with schizophrenia and bipolar disorder. Biol Psychiatry 69:188-193
39. Payne NA, Prudic J (2009) Electroconvulsive therapy Part I: a perspective on the evolution and current practice of ECT. J Psychiatr Pract 15:346-368
40. Peedicayil J (2001) The importance of cultural inheritance. Med Hypotheses 56:158-159 (Pubitemid 32202620)
41. Peedicayil J (2006) Epigenetic therapy-a new development in pharmacology. Indian J Med Res 123:17-24
42. Peedicayil J (2007) The role of epigenetics in mental disorders. Indian J Med Res 126:105-111 (Pubitemid 350028041)
43. Peedicayil J (2008) Epigenetic biomarkers in psychiatric disorders. Br J Pharmacol 155:795-796
44. Peedicayil J (2010) Epigenetic basis of individual variability to major psychosis. Curr Pharmacogenom Person Med 8:232-239
45. Perkins DO, Jeffries CD, Jarskog LF, Thomson JM, Woods K, Newman MA, Parker JS, Jin J, Hammond SM (2007) microRNA expression in the prefrontal cortex of individuals with schizophrenia and schizoaffective disorder. Genome Biol 8:R27
46. Porter RJ, Meldrum BS (2009) Antiseizure drugs. In: Basic and Clinical Pharmacology. Eds: Katzung BG, Masters SB, Trevor AJ. Tata McGraw-Hill, Mumbai, pp 399-422.
47. Ptak C, Petronis A (2008) Epigenetics and complex disease: from etiology to new therapeutics. Annu Rev Pharmacol Toxicol 48:257-276 (Pubitemid 351738154)
48. Reichenberg A, Mill J, MacCabe JH (2009) Epigenetics, genomic mutations and cognitive function. Cogn Neuropsychiatry 14:377-390
49. Riccio A (2010) Dynamic epigenetic regulation in neurons: enzymes, stimuli and signaling pathways. Nat Neurosci 13:1330-1337
50. Roth TL, Lubin FD, Sodhi M, Kleinman JE (2009) Epigenetic mechanisms in schizophrenia. Biochim Biophys Acta 1790:869-877
51. Rutten BPF, Mill J (2009) Epigenetic mediation of environmental influences in major psychotic disorders. Schizophr Bull 35:1045-1056
52. Sadock BJ, Sadock VA (2007) Kaplan & Sadock's Synopsis of Psychiatry. Lippincott Williams & Wilkins, Philadelphia
53. Sanosaka T, Namihira M, Nakashima K (2009) Epigenetic mechanisms in sequential differentiation of neural stem cells. Epigenetics 4:89-92
54. Sharma RP, Grayson DR, Gavin DP (2008) Histone deacetylase 1 expression is increased in the prefrontal cortex of schizophrenia subjects: analysis of the National Brain Databank microarray collection. Schizophr Res 98:111-117 (Pubitemid 350235899)
55. Simonini MV, Camargo LM, Dong E, Maloku E, Veldic M, Costa E, Guidotti A (2006) The benzamide MS-275 is a potent, longlasting brain region-selective inhibitor of histone deacetylases. Proc Natl Acad Sci USA 103:1587-1592 (Pubitemid 43191209)
56. Stadler F, Kolb G, Rubusch L, Baker SP, Jones EG, Akbarian S (2005) Histone methylation at gene promoters is associated with developmental regulation and region-specific expression of ionotropic and metabotropic receptors in human brain. J Neurochem 94:324-336 (Pubitemid 40995249)
57. Tremolizzo L, Carboni G, Ruzicka WB, Mitchell CP, Sugaya I, Tueting P, Sharma R, Grayson DR, Costa E, Guidotti A (2002) An epigenetic mouse model for molecular and behavioral neuropathologies related to schizophrenia vulnerability. Proc Natl Acad Sci USA 99:17095-17100 (Pubitemid 36034104)
58. Tremolizzo L, Doueiri M-S, Dong E, Grayson DR, Davis J, Pinna G, Tueting P, Rodriguez-Menendez V, Costa E, Guidotti A (2005) Valproate corrects the schizophrenia-like epigenetic behavioral modifications induced by methionine in mice. Biol Psychiatry 57:500-509 (Pubitemid 40311985)
59. Tsankova NM, Kumar A, Nestler EJ (2004) Histone modifications at gene promoter regions in rat hippocampus after acute and chronic electroconvulsive seizures. J Neurosci 24:5603-5610 (Pubitemid 38812643)
60. Tsankova NM, Berton O, Renthal W, Kumar A, Neve RL, Nestler EJ (2006) Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action. Nat Neurosci 9:519-525
61. Veldic M, Caruncho HJ, Liu ES, Davis J, Satta R, Grayson DR, Guidotti A, Costa E (2004) DNA-methyltransferase 1 mRNA is selectively overexpressed in telencephalic GABAergic interneurons of schizophrenia brains. Proc Natl Acad Sci USA 101:348-353 (Pubitemid 38084253)
62. Veldic M, Guidotti A, Maloku E, Davis JM, Costa E (2005) In psychosis, cortical interneurons overexpress DNA-methyltransferase 1. Proc Natl Acad Sci USA 102:2152-2157 (Pubitemid 40262027)
63. Veldic M, Kadriu B, Maloku E, Agis-Balboa RC, Guidotti A, Davis JM, Costa E (2007) Epigenetic mechanisms expressed in basal ganglia GABAergic neurons differentiate schizophrenia from bipolar disorder. Schizophr Res 91:51-61
64. Wassef AA, Dott SG, Harris A, Brown A, O'Boyle M, Meyer WJ, Rose RM (2000) Randomized, placebo-controlled pilot study of divalproex sodium in the treatment of acute exacerbations of chronic schizophrenia. J Clin Psychopharmacol 20:357-361 (Pubitemid 30318366)
65. Zhou R, Yuan P, Wang Y, Hunsberger JG, Elkahloun A, Wei Y, Damschroder-Williams P, Du J, Chen G, Manji HK (2009) Evidence for selective microRNAs and their effectors as common long-term targets for the actions of mood stabilizers. Neuropsychopharmacology 34:1395-1405